Montelukast oral dispersible film

Drug Profile

Montelukast oral dispersible film

Alternative Names: Montelukast Na film; Montelukast ODF; Montelukast PharmaFilm®

Latest Information Update: 20 Aug 2014

Price : $50

At a glance

  • Originator MonoSol Rx
  • Class Acetates; Antiasthmatics; Quinolines; Small molecules
  • Mechanism of Action Leukotriene D4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Clinical Phase Unknown Allergic rhinitis; Asthma

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 20 Aug 2014 Clinical trials in Allergic rhinitis in USA (Transmucosal)
  • 20 Aug 2014 Clinical trials in Asthma in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top